Back to Journals » ImmunoTargets and Therapy » Volume 6

FDA-approved immunosuppressants targeting staphylococcal superantigens: mechanisms and insights

Total article views   HTML views PDF downloads Totals
11,440 Dovepress* 10,273+ 1,580 11,853
PubMed Central* 1,167 249 1,416
Totals 11,440 1,829 13,269
*Since 2 May 2017

View citations on PubMed Central and Google Scholar